The main objective of this study is to gain a deeper understanding of how patients suffering from chronic myeloid leukemia (CML) cope with their illness. The study aims to reconstruct the subjective meaning-making process related to CML in order to gain insights into the impact the disease has on patients’ emotions and everyday lives, as well as to explore the psychological impact of their being presented with the chance to suspend their therapy and recover from the disease.
Data were gathered from a qualitative study conducted in Italy on 158 Italian CML patients. Basing the study on the narrative inquiry approach, the patients were required to describe their patient journey in a qualitative narrative diary. These contained prompts to elicit the free expression of their needs, expectations, and priorities. A lexicographic analysis was carried out with T-LAB software and in particular a thematic analysis of elementary contexts (TAECs) and a word association analysis (WAA).
The TAEC detected four thematic clusters related to two factors (temporal frame and contextual setting) that explained the variance among the narratives. The WAA evidenced a wide variety of emotions, both positive and negative, as patients reacted to the possibility of interrupting their therapy.
A better understanding of patients’ experiences can offer insights into promoting the development of more sustainable healthcare services and into therapeutic innovation aimed at improving patients’ quality of life and at engaging them more in their treatment. The findings of this study can also help make medical professionals more aware of the patient’s burden and help them identify potential interactions and emotional levers to improve clinical relationships.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Sawyers, C. L., Hochhaus, A., Feldman, E., Goldman, J. M., Miller, C. B., Ottmann, O. G., et al. (2002). Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: Results of a phase II study. Blood, 99(10), 3530–3539.
Hanfstein, B., Müller, M. C., Hehlmann, R., Erben, P., Lauseker, M., Fabarius, A., et al. (2012). Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia, 26(9), 2096–2102. doi:10.1038/leu.2012.85.
Steegmann, J. L., Baccarani, M., Breccia, M., Casado, L. F., García-Gutiérrez, V., Hochhaus, A., et al. (2016). European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. Leukemia, 2016(3), 1648–1671.
Efficace, F., Baccarani, M., Breccia, M., Alimena, G., Rosti, G., Cottone, F., et al. (2011). Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. Blood, 118(17), 4554–4560.
Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion, 32(8), 1453–1454. doi:10.1080/03007995.2016.1185399.
Baccarani, M., Efficace, F., & Rosti, G. (2014). Moving towards patient-centered decision-making in chronic myeloid leukemia: Assessment of quality of life and symptom burden. Haematologica, 99(2), 205–208. doi:10.3324/haematol.2013.094045.
Barello, S., & Graffigna, G. (2015). Engagement-sensitive decision making: Training doctors to sustain patient engagement in medical consultations. In G. Graffigna, S. Barello, & S. Triberti (Eds.), Patient engagement: A consumer-centered model to innovate healthcare (pp. 78–89). Berlin: DeGruyter Open.
Shortell, S. M. (2013). Bridging the divide between health and health care. JAMA, 309(11), 1121–1122. doi:10.1001/jama.2013.887.
Street, R. L., Jr., Gordon, H. S., Ward, M. M., Krupat, E., & Kravitz, R. L. (2005). Patient participation in medical consultations: Why some patients are more involved than others. Medical Care, 43(10), 960–969.
Barello, S., & Graffigna, G. (2015). Patient engagement in healthcare: Pathways for shared decision-making. Neuropsychological Trends, 17, 53–65. doi:10.7358/neur-2015-017.
Guilhot, F., Coombs, J., Szczudlo, T., Zernovak, O., Paolantonio, M., Christina, B., et al. (2013). The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: Qualitative insights using a global ethnographic approach. The Patient: Patient-Centered Outcomes Research, 6(2), 81–92.
Baccarani, M., Saglio, G., Goldman, J., Hochhaus, A., Simonsson, B., Appelbaum, F., et al. (2006). Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 108(6), 1809–1820.
Efficace, F., Baccarani, M., Breccia, M., Cottone, F., Alimena, G., Deliliers, G. L., et al. (2013). Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia, 27(7), 1511–1519.
Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion. doi:10.1080/03007995.2016.1185399.
Cortes, J., De Souza, C., Ayala-Sanchez, M., Bendit, I., Best-Aguilera, C., Enrico, A., et al. (2010). Current patient management of chronic myeloid leukemia in Latin America. Cancer, 116(21), 4991–5000. doi:10.1002/cncr.25273.
Rood, J. A. J., Van Zuuren, F. J., Stam, F., Van Der Ploeg, T., Huijgens, P. C., & Verdonck-de Leeuw, I. M. (2015). Cognitive coping style (monitoring and blunting) and the need for information, information satisfaction and shared decision making among patients with haematological malignancies. Psycho-Oncology, 24(5), 564–571. doi:10.1002/pon.3699.
Efficace, F., Rosti, G., Aaronson, N., Cottone, F., Angelucci, E., Molica, S., et al. (2014). Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica, 99(4), 788–793. doi:10.3324/haematol.2013.093724.
Coulter, A. (2011). Engaging patients in healthcare. New York: University Press.
Kleinman, A. (1978). Concepts and a model for the comparison of medical systems as cultural systems. Social Science and Medicine Part B: Medical Anthropology, 12, 85–93.
Graffigna, G., Barello, S., Riva, G., & Bosio, A. C. (2014). Patient engagement: The key to redesign the exchange between the demand and supply for healthcare in the era of active ageing. Studies in Health Technology and Informatics, 203, 85–95.
Charon, R. (2012). At the membranes of care: Stories in narrative medicine. Academic Medicine, 87(3), 342–347. doi:10.1097/ACM.0b013e3182446fbb.
Vegni, E., Zannini, L., Visioli, S., & Moja, E. A. (2001). Giving bad news: A GPs’ narrative perspective. Supportive Care in Cancer, 9(5), 390–396.
Charon, R. (2007). What to do with stories: The sciences of narrative medicine. Canadian Family Physician, 53(8), 1265–1267.
Greenhalgh, T. (1999). Narrative based medicine in an evidence based world. BMJ, 318(7179), 323–325.
Vegni, E., Visioli, S., & Moja, E. A. (2005). When talking to the patient is difficult: The physician’s perspective. Communication and Medicine, 2(1), 69–76. doi:10.1515/come.2005.2.1.69.
Greenhalgh, T., & Hurwitz, B. (1999). Why study narrative? BMJ, 318(7175), 48–50.
Elwyn, G., Edwards, A., Kinnersley, P., & Grol, R. (2000). Shared decision making and the concept of equipoise: The competences of involving patients in healthcare choices. British Journal of General Practice, 50(460), 892–899.
Hibbard, J. H., Stockard, J., Mahoney, E. R., & Tusler, M. (2004). Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Services Research, 39(4), 1005–1026. doi:10.1111/j.1475-6773.2004.00269.x.
Frank, A. W. (1995). The wounded storyteller. Chicago: University of Chicago Press.
Riley, T., & Hawe, P. (2005). Researching practice: The methodological case for narrative inquiry. Health Education Research, 20(2), 226–236.
Muller, J. H. (1999). Narrative approaches to qualitative research in primary care. In B. F. Crabtree & W. L. Miller (Eds.), Doing qualitative research (pp. 221–238). Thousand Oaks, CA: Sage Publications.
Frank, A. W. (1998). Just listening: Narrative and deep illness. Families, Systems, and Health, 16(3), 197.
Mishler, E. G. (1996). Language, meaning, and narrative analysis. In Research interviewing. Context and narrative (pp. 66–116). Cambridge, MA: Harvard University Press.
Smith, C. P. (2000). Content analysis and narrative analysis. In H. T. Reis & C. M. Judd (Eds.), Handbook of research methods in social and personality psychology. Cambridge: Cambridge University Press.
Bellardita, L., Graffigna, G., Donegani, S., Villani, D., Villa, S., Tresoldi, V., et al. (2012). Patient’s choice of observational strategy for early-stage prostate cancer. Neuropsychological Trends, 12(1), 107–116.
Gambetti, R., & Graffigna, G. (2010). The concept of engagement: A systematic analysis of the ongoing debate. International Journal of Marketing Research, 52(6), 7.
Lancia, F. (2004). Strumenti per l’analisi dei testi. Introduzione all’uso di T-LAB. Milano: Franco Angeli.
Sontag, S., & Broun, H. H. (1977). Illness as metaphor (p. 343). N. Hollywood: Center for Cassette Studies.
Skott, C. (2002). Expressive metaphors in cancer narratives. Cancer Nursing, 25(3), 230–235.
Olsson, C., Sandin-Bojö, A. K., Bjuresäter, K., & Larsson, M. (2015). Patients treated for hematologic malignancies: Affected sexuality and health-related quality of life. Cancer Nursing, 38(2), 99–110.
Cella, D., Nowinski, C. J., & Frankfurt, O. (2014). The impact of symptom burden on patient quality of life in chronic myeloid leukemia. Oncology, 87(3), 133–147.
Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. New York: Springer.
Prochaska, J. O., & Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion, 12(1), 38–48.
Graffigna, G., Barello, S., & Triberti, S. (2015). Patient engagement: a consumer centered approach. Warsaw: De Gruyter Open.
Kübler-Ross, E. (2009). On death and dying: What the dying have to teach doctors, nurses, clergy and their own families. New York: Scribner.
Barello, S., & Graffigna, G. (2015). Engaging patients to recover life projectuality: An Italian cross-disease framework. Quality of Life Research, 24(5), 1087–1096.
Andresen, R., Oades, L., & Caputi, P. (2003). The experience of recovery from schizophrenia: Towards an empirically validated stage model. Australian and New Zealand Journal of Psychiatry, 37(5), 586–594.
Goldberg, R. J. (1983). Systematic understanding of cancer patients who refuse treatment. Psychotherapy and Psychosomatics, 39(3), 180–189.
Charon, R. (2001). Narrative medicine: A model for empathy, reflection, profession, and trust. JAMA, 286(15), 1897–1902.
This study was liberally funded by Novartis Italia.
GG and IC designed, conducted, and managed the entire study. GG wrote the first draft of the paper. BM thoroughly revised the paper and offered insights for improving the analysis. CE, DSR, GS, MA, SF, PM, CS, FF, MP, DRN, ML, RD, OE, IT, IA, PE, and PM recruited patients for the study and supported the data collection. They also revised the paper and made suggestions for improvement of its medical background.
Conflict of interest
All authors declare that they have no conflict of interest to be disclosed.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
About this article
Cite this article
Graffigna, G., Cecchini, I., Breccia, M. et al. Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine. Qual Life Res 26, 2739–2754 (2017). https://doi.org/10.1007/s11136-017-1611-8
- Chronic myeloid leukemia
- Illness experience
- Patients’ psychological representations
- Narrative inquiry approach
- Patient engagement